Claude Poirier

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

Stopping<i>versus</i>continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study)

Wendy C. Moore, Oliver Kornmann, Marc Humbert et al. · European Respiratory Journal · 2021 · 117 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

&lt;p&gt;Ultrasound Evaluation of the Quadriceps Muscle Contractile Index in Patients with Stable Chronic Obstructive Pulmonary Disease: Relationships with Clinical Symptoms, Disease Severity and Diaphragm Contractility&lt;/p&gt;

Anne-Catherine Maynard-Paquette, Claude Poirier, Carl Chartrand‐Lefebvre et al. · International Journal of COPD · 2020 · 31 citations · Full text

Medicine, Radiology, Pulmonology +14

Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

Renaud Louis, Tim Harrison, Pascal Chanez et al. · The Journal of Allergy and Clinical Immunology In Practice · 2023 · 24 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

Effects of Pursed Lip Breathing on Exercise Capacity and Dyspnea in Patients With Interstitial Lung Disease

Stéfanie Parisien‐La Salle, Ellie Abel Rivest, Vincent Gosselin Boucher et al. · Journal of Cardiopulmonary Rehabilitation and Prevention · 2019 · 20 citations

Medicine, Physical Medicine, Rehabilitation Medicine +17